CURRENT HEADLINES
- Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
- Massive Bio And NeoGenomics Announce Collaboration To Accelerate Oncology Drug Discovery And Improve Patient Care
- Invitae And Deerfield Management Partner To Create Novel Therapeutics For Rare Diseases
- Dewpoint Therapeutics Partners With Novo Nordisk To Explore The Field Of Biomolecular Condensates To Treat Insulin Resistance And Diabetes Progression
- Gyros Protein Technologies Introduces New PurePep EasyClean Services To Accelerate Development And Manufacturing Of Peptide-Based Drugs
SUPPLIER NEWS
- New 50 Microliter Electronic Pipettes
- Powerful Evaporator For Drug Discovery
- Capsugel Expands Global Manufacturing For Finished Dosage Forms
- CAMO Releases New Version Of The Unscrambler® X Multivariate Data Analysis And Design Of Experiments Software
- Leading Vaccine Manufacturer Boosts IT Efficiency And Reduces TCO By 20%
ARCHIVE NEWSLETTER
- 03.22.23 -- Optimize Product Life Cycles With A Collaborative Partnership Model
- 03.21.23 -- Tangential Flow Filtration For Laboratory And Process Development Applications
- 03.21.23 -- In 2023, What Trends Will Dominate Cybersecurity?
- 03.15.23 -- Antibody Variants Chromatography, And Mechanistic Modeling Trends
- 03.14.23 -- Automating Instrument Data Ingestion And Access To Accelerate Lab Productivity
BUSINESS WIRE PRESS
- Massive Bio And NeoGenomics Announce Collaboration To Accelerate Oncology Drug Discovery And Improve Patient Care
- Gyros Protein Technologies Introduces New PurePep EasyClean Services To Accelerate Development And Manufacturing Of Peptide-Based Drugs
- Lumicell Submits New Drug Application For LUMISIGHT Optical Imaging Agent To U.S. FDA For Intraoperative Breast Cancer Detection And Removal
- Arrowhead Receives FDA Fast Track Designation For ARO-APOC3
- Icosagen Acquires The Carterra LSA Instrument To Significantly Enhance Its Antibody Screening Capabilities In The Discovery And Development Of New Therapeutic And Diagnostic Antibodies
- ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces A Multi-Target AI-Driven Antibody Discovery Collaboration With Libera Bio
DOWNLOAD LIBRARY

| Download software |
EVENTS CALENDAR

| Search events |
| Post events |
| Stay informed |
Learn more...
ASSOCIATIONS
Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...This website uses cookies to ensure you get the best experience on our website. Learn more